Glyburide and Metformin News : GoldBamboo.com http://goldbamboo.com/ Glyburide and Metformin News from GoldBamboo.com en-us © 2005, Gold Bamboo LLC, All Rights Reserved Women Taking Clomiphene More Likely To Become Pregnant Than Women Taking Metformin, NEJM Study Says http://goldbamboo.com/news-a220912.html Women who have polycystic ovary syndrome and take the drug clomiphene are more likely to become pregnant than women with PCOS who take the drug metformin, according to a study published in the Feb. 8 issue of the New England Journal of Medicine, the Washington Post reports (Washington Post, 2/13). PCOS is a hormonal imbalance that affects approximately 5% to 10% of U.S. [click link for full article] Thu, 15 Feb 2007 05:00 EST Standard Therapy More Effective Than Diabetes Drug In Helping Women With PCOS Achieve Pregnancy http://goldbamboo.com/news-a220138.html Metformin, a drug used to treat diabetes and once thought to have great promise in overcoming the infertility associated with polycystic ovary syndrome (PCOS), is less effective than the standard fertility drug treatment, clomiphene, according to researchers from the University of Pennsylvania School of Medicine and the National Institutes of Health Reproductive Medicine research network. [click link for full article] Sun, 11 Feb 2007 04:00 EST Standard Therapy More Effective Than Diabetes Drug for Achieving Pregnancy in Common Fertility Disorder - February 7, 2007 http://goldbamboo.com/news-a219706.html Metformin, a drug used to treat diabetes and thought to hold great promise at overcoming the infertility associated with polycystic ovary syndrome (PCOS), is less useful for helping women with the condition achieve pregnancy than is the standard treatment with the infertility drug clomiphene, report researchers in an NIH research network. Thu, 08 Feb 2007 03:07 EST Diabetes Drugs Compared http://goldbamboo.com/news-a210296.html A new study comparing three major diabetes drugs -- Avandia, Glucophage (metformin), and Micronase (glyburide) -- shows that all three drugs have pros and cons to consider. Wed, 06 Dec 2006 09:12 EST Landmark Study Shows Avandia(R) (rosiglitazone Maleate) Is More Effective Than Metformin Or A Sulfonylurea In Long-Term Blood Sugar Control http://goldbamboo.com/news-a209949.html Results from ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial treatment with Avandia(R) (rosiglitazone maleate) reduced the risk of monotherapy failure in people with type 2 diabetes by 32 percent compared to metformin (p180 mg/dl (10 mmol/l) to a lower blood sugar level more consistent with current therapeutic approaches, FPG 140 mg/dl (7.8 mmol/l). [click link for full article] Tue, 05 Dec 2006 08:00 EST